Oral Mineralocorticoid-Receptor Antagonists: Real-Life Experience in Clinical Subtypes of Nonresolving Central Serous Chorioretinopathy With Chronic Epitheliopathy

PURPOSE: To evaluate the efficacy and safety of oral mineralocorticoid-receptor antagonist (MRa) therapy in three clinical presentations of nonresolving central serous chorioretinopathy (CSCR) with chronic epitheliopathy. METHODS: Retrospective case series of consecutive patients with nonresolving C...

Descripción completa

Detalles Bibliográficos
Autores principales: Daruich, Alejandra, Matet, Alexandre, Dirani, Ali, Gallice, Mathilde, Nicholson, Luke, Sivaprasad, Sobha, Behar-Cohen, Francine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Association for Research in Vision and Ophthalmology 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782825/
https://www.ncbi.nlm.nih.gov/pubmed/26966638
http://dx.doi.org/10.1167/tvst.5.2.2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782825/
https://www.ncbi.nlm.nih.gov/pubmed/26966638
http://dx.doi.org/10.1167/tvst.5.2.2

Ejemplares similares